Evidence map›Paper›PMID 40035948›Full record

ReviewAnalytical sciences : the international journal of the Japan Society for Analytical Chemistry2025

Nanobiodevices and quantum life science for future healthcare.

Taisuke Shimada, Takao Yasui, Hiroshi Yukawa, Yoshinobu Baba

Abstract readReview
PubMed Publisher
In one paragraph

Review in Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Taisuke ShimadaInstitute for Quantum Life Science, National Institutes for Quantum Science and Technology (QST), Anagawa 4-9-1, Inage-ku, Chiba, 263-8555, Japan. shimada.taisuke@qst.go.jp.ORCID http://orcid.org/0000-0002-4451-2433
Takao YasuiInstitute for Quantum Life Science, National Institutes for Quantum Science and Technology (QST), Anagawa 4-9-1, Inage-ku, Chiba, 263-8555, Japan.
Hiroshi YukawaInstitute for Quantum Life Science, National Institutes for Quantum Science and Technology (QST), Anagawa 4-9-1, Inage-ku, Chiba, 263-8555, Japan.
Yoshinobu BabaInstitute for Quantum Life Science, National Institutes for Quantum Science and Technology (QST), Anagawa 4-9-1, Inage-ku, Chiba, 263-8555, Japan. baba.yoshinobu@qst.go.jp.

Funding

Ministerio de Educación, Cultura y Deporte JPMXS0120330644
6 · The paper itself

Abstract

Maintaining healthy life in old age (healthy aging) is an important social challenge. An effective approach to realizing healthy aging involves providing personalized healthcare through disease prevention, early diagnostics, and optimal treatments. Nanobiodevices and quantum life sciences have tremendous potential to revolutionize current techniques for disease prevention, diagnostics, and treatment via the efficient analyses of biomolecules, bioparticles, pathogens, and cells. In this review, we outline our research on nanobiodevices and quantum life sciences for future healthcare, including cancer diagnostics, pathogen detection, in vivo imaging-guided therapy, and intracellular sensing for stem cell quality checks.

Indexed as

Biological Science DisciplinesDelivery of Health CareNanotechnologyQuantum TheoryHumansCancer diagnosticsCancer theranosticsIntracellular sensingNanobiodevicesPathogen detectionQuantum life science

Identifiers

PMID40035948

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.